“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: The role of ADAMTS13 and VWF in Patients with Acute Ischemic Stroke: a Case Control Study

€3.03

SKU: product-article-19198 Category: General

Description
Reviews (0)

Description

The role of ADAMTS13 and VWF in Patients with Acute Ischemic Stroke: a Case Control Study

Reviews

There are no reviews yet.

Be the first to review “Article: The role of ADAMTS13 and VWF in Patients with Acute Ischemic Stroke: a Case Control Study”

You must be logged in to post a review.

Top

Article: The role of ADAMTS13 and VWF in Patients with Acute Ischemic Stroke: a Case Control Study

Description

Reviews

Related products

Article: INTRODUCTION

Article: Highlights in melanoma

Article: Highlights in genitourinary cancers

Article: Highlights in breast cancer